Clinical Trial Update: A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating different fludarabine dosing regimens in children and young adults with B-cell acute lymphoblastic leukemia; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Fludarabine (Fludarabine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: B-cell Acute Lymphoblastic Leukemia | Phase 3 | Status: RECRUITING